Overcoming Solubility Challenges in Early-Phase Drug Formulation
Poor solubility is one of the most common challenges encountered during early-stage drug development. When an active pharmaceutical ingredient (API) […]
PharmSky Research at Australia–France Clinical Trials Seminar
PharmSky Research to Participate in Australia–France Clinical Trials Seminar PharmSky Research will participate in the Australia–France Clinical Trials Seminar, taking
PharmSky Research to Attend BIO-Europe Spring 2026
PharmSky Research will attend BIO-Europe Spring 2026, taking place from 23–25 March 2026 in Lisbon, Portugal. As part of our
PharmSky Research at Clinical Trials Festival Asia
PharmSky Research will participate in Clinical Trials Festival Asia 2026, taking place from 10–12 March in Singapore. Murali Nair, Director
Preparing for an Analytical Audit: What Pharma Companies Need to Know
Analytical audits play a critical role in ensuring pharmaceutical products meet regulatory standards for safety, quality, and consistency. Being prepared
Immediate vs Modified Release Formulations: What’s Right for Your Drug Candidate?
When developing a new drug product, choosing the right release profile is critical. Immediate and modified release formulations offer distinct
How Formulation Decisions Impact Drug Stability and Bioavailability
The success of a pharmaceutical product hinges not only on the active ingredient, but also on how that ingredient is
How Analytical Method Validation Ensures Product Quality
Analytical method validation is essential to pharmaceutical development. It confirms that each test method produces reliable and reproducible data, supporting
Why Do Drug Development in Australia?
Australia has become a global hub for early-phase drug development – and not just because of the sunshine. With its
PharmSky Research at BIO-Europe 2025
PharmSky Research will participate in BIO-Europe 2025, taking place from November 3–5, 2025, at the Vienna Congress and Convention Center,
